Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Pfizer’s Covid Boost Crashes to Earth
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
Big Pharma Bets Big on China
China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link
Silicon Valley Money Men Are Buzzing About Robert F. Kennedy Jr.
Twitter co-founder Jack Dorsey and others are praising the antiestablishment candidate, who is running for the Democratic Party’s presidential nomination. Source link
FDA Approves First Over-the-Counter Birth-Control Pill
The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly expanding access to contraception among women across the U.S. Source link
Obesity Drugs Won't Starve These Other Potential Blockbusters
Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were published last week. Source link
FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
Kidney-Care Specialist Diaverum Expected to Be Sold in $2 Billion Deal
Mubadala-backed M42 would buy the operator of 440 dialysis clinics from buyout firm Bridgepoint. Source link
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
Merck in Late-Stage Talks to Acquire Prometheus Biosciences
Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the
The 'King Kong' of Weight-Loss Drugs Is Coming
Eli Lilly’s Mounjaro could outpace Ozempic as the most powerful treatment on the market. To develop it, the drug company needed to overhaul long-held but
